Legend Biotech Corporation (LEGN) Next Earnings Date & Options-Implied ±7% Move
Legend Biotech Corporation (LEGN) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Options-Implied Post-Earnings ±7% Bell Curve
Will LEGN Beat & Rip or Miss Next Quarter?
Trailing EPS: $0.68 • YoY Revenue Growth: 9.9%
Whale Flow & Momentum Playbook: Trading LEGN & AI Leaders Without Chasing Tops
- ✓Exact institutional whale strikes & implied earnings range on LEGN this week
- ✓How active traders scale setups using funded prop-firm accounts instead of risking savings
- ✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders
LEGN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +9.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on LEGN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for LEGN. Explore sector supply chains on /butterfly.
LEGN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is LEGN's next earnings date?
Based on SEC filing cadence, Legend Biotech Corporation (LEGN)'s next quarterly earnings window is estimated around Upcoming Quarter.
How much is LEGN stock expected to move on earnings?
Options markets currently imply a ±7% post-earnings move for LEGN, projecting a trading range between $20.74 and $23.86.